Genentech whistleblower awarded $10 million in FCA settlement
Image courtesy of GenentechA former Genentech product manager who alleged his company exaggerated the effectiveness of the drug Tarceva to treat lung cancer will collect more than $10 million as part of a False Claims Act settlement.… Continue Reading